Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
07/2010
07/08/2010US20100173917 Urea derivatives as abl modulators
07/08/2010US20100173778 3-Biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
07/08/2010CA2748982A1 Thienopyridines as pharmacologically active agents
07/08/2010CA2748413A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010CA2748276A1 Substituted pyrazolo [3, 4-b] pyridine compounds
07/08/2010CA2745503A1 Novel oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
07/08/2010CA2745071A1 C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof
07/07/2010EP1765829B1 Tricyclic compounds and their use as mglur1 antagonists
07/07/2010CN101768166A Preparation method of 3,4-alkyl dioxythiophene
07/06/2010US7750160 inhibit p38, MAP kinase interacting serine/threonine kinase 2 (MKNK2 kinase) and serine-threonine kinases (STKs); treating proliferative diseases including cancer, leukemias; e.g. N-(isoxazolyl)urea compounds and thiourea compounds
07/06/2010US7750034 Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
07/06/2010US7750002 Anticancer agents; kinase inhibitors; viricides; antiinflammatory agents; immunotherapy; metabolism disorders
07/01/2010WO2010075469A1 Corydaline derivatives useful for reducing lipid levels
07/01/2010WO2010073706A1 Improved process for producing intermediate for side chain of carbapenem
07/01/2010WO2010037851A3 Indole derivatives suitable for imaging neuroinflammation
07/01/2010US20100168444 Diindenothiophene derivatives and use thereof
07/01/2010US20100168158 Modulators of cystic fibrosis transmembrane conductance regulator
07/01/2010US20100168157 Preventive and therapeutic medicament for gastroesophageal reflux disease
07/01/2010US20100167936 Use of ascorbic acid derivatives for the functionalization of matrices
07/01/2010CA2772760A1 Small molecule inhibitors of necroptosis
06/2010
06/30/2010EP2200595A2 Thieno-and furo-pyrimidine modulators of the histamine h4 receptor
06/30/2010EP2200440A1 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
06/29/2010US7745622 Crystalline N-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-N′-(2-fluoro-5-(trifluoromethyl)phenyl)urea benzenesulfonate
06/29/2010US7745483 2-Halofuryl-thienyl-3-carboxamides
06/29/2010US7745449 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
06/29/2010US7745448 Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N′-(2-fluoro-5-(trifluoromethyl)phenyl)urea ethanolate
06/29/2010US7745447 6-(4-Chlorophenyl)-3-(5-hydroxypyridin-2-yl)thieno[3,2-d]pyrimidin-4(3H)-one, for example; for treating a patient suffering from an MCHR-1 modulated disease or disorder such as obesity, diabetes, depression or anxiety
06/29/2010US7745429 Crystal forms of olanzapine and processes for their preparation
06/29/2010CA2409090C Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
06/29/2010CA2336967C A3 adenosine receptor antagonists
06/29/2010CA2306409C Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates
06/24/2010WO2009068924A8 Process for the preparation of pharmaceutical i nterm ediates
06/24/2010US20100160645 Poly(ethylene glycol) containing chemically disparate endgroups
06/24/2010US20100160635 Industrial process for preparation of clopidogrel hydrogen sulphate
06/24/2010US20100160336 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors
06/24/2010US20100160327 Modified Malonate Derivatives
06/23/2010EP2199295A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
06/23/2010EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors
06/23/2010EP2197886A1 5-cyano-thienopyridines for the treatment of tumors
06/23/2010EP2197552A2 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
06/23/2010EP2024372B1 Thieno[3,2-d]pyrimidine derivative useful as pi3k inhibitor
06/23/2010CN1906173B Protein modifier production inhibitor
06/23/2010CN101747339A 1'-thio-aza indirubin compound, application and preparation method thereof
06/23/2010CN101072780B Novel tetracyclic derivative containing heteroatoms useful as sex steroid hormone receptor modulators
06/23/2010CN101039908B Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
06/22/2010US7741341 Benzimidazole-derivatives as factor Xa inhibitors
06/22/2010CA2410408C 2-aminoalkylthieno[2,3-d]pyrimidines
06/17/2010WO2010067085A2 Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-υ-carboline and analogues and intermediates
06/17/2010WO2010066658A1 Compounds which potentiate the ampa receptor and uses thereof in medicine
06/17/2010WO2010027236A3 Fused heterocyclic compound
06/17/2010US20100152338 Nonlinear optical material composition and method of manufacture
06/17/2010US20100152219 Pyrazole derivatives as inhibitors of receptor tyrosine kinases
06/17/2010US20100152207 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
06/17/2010US20100152200 Alphavirus inhibitors and uses thereof
06/17/2010US20100152195 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors
06/17/2010US20100152171 CGRP Antagonists
06/16/2010EP2196462A1 Polymerizable compound, lactone-containing compound, method for manufacturing lactone-containing compound and polymer compound obtained by polymerizing the polymerizable compound
06/16/2010EP2195316A1 Activators and therapeutic applications thereof
06/16/2010EP1784409B1 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon
06/16/2010CN1922189B Spirocyclic cyclohexane derivatives with affinity for the ORL1-receptor
06/16/2010CN1894258B Compositions useful as inhibitors of protein kinases
06/16/2010CN1867566B Aminopyrones and their use as ATM inhibitors
06/16/2010CN101743223A Novel compounds as cannabinoid receptor ligands
06/16/2010CN101735242A Method for preparing D-(+)-biotin intermediate
06/16/2010CN101735241A Prasugrel intermediate and preparation method thereof
06/16/2010CN101735240A New preparation method for hexahydrothieno [3, 2-c] pyridine derivatives
06/16/2010CN101735239A Preparation method of anhydrous olanzapine crystal form II
06/16/2010CN101735209A Method for synthesizing chiral dorzolamide hydrochloride
06/16/2010CN101120003B Thieno-pyridine derivatives as GABA-B allosteric enhancers
06/16/2010CN101048403B Heterocyclic antiviral compounds
06/15/2010US7737269 Process for preparing an alpha-lipoic acid/cyclodextrin complex and product prepared
06/15/2010US7737235 Vinyl monomer and polymer derived from the monomer, and light emitting device using the polymer
06/15/2010US7737160 Protein tyrosine kinase inhibitors such as N-[4-(4-aminothieno[3,2-]pyridin-3-yl)-2-fluorophenyl]-N'-(3'-methylphenyl)urea, used for treating lung, breast, colon or hematopoietic cancer
06/15/2010US7737145 Diamine derivatives as inhibitors of leukotriene A4 hydrolase
06/15/2010CA2518224C Novel isothiazolopyrimidinones and isoxazolopyrimidinones and uses thereof
06/15/2010CA2383340C Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists
06/10/2010WO2010065825A2 Kinase inhibitors with improved cyp safety profile
06/10/2010WO2010027875A3 Compounds that modulate intracellular calcium
06/10/2010US20100145056 Acetyl 2-hydroxy-1,3-diaminoalkanes
06/10/2010US20100145053 Modified release clopidogrel formulation
06/10/2010US20100145052 Fused tricyclic compound having aldose reductase inhibitory activity
06/10/2010US20100145050 Orthogonally fixed compounds for electrooptical applications
06/10/2010US20100144783 Kinase inhibitors with improved cyp safety profile
06/10/2010US20100144765 5,6-trimethylenepyrimidin-4-one compounds
06/10/2010US20100144744 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
06/10/2010US20100144735 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
06/10/2010US20100143341 Thienopyrimidines for pharmaceutical compositions
06/10/2010CA2743592A1 Kinase inhibitors with improved cyp safety profile
06/09/2010CN1852712B Dual NK1/NK3 antagonists for treating schizophrenia
06/09/2010CN1780835B Novel fused heterocycles and uses thereof
06/09/2010CN101730689A 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators
06/09/2010CN101723956A Crystal transformation process of (3,5-bis-trifluoromethyl)-6-amino-4H-(1,2) dithiol (4,3-b) pyrrole-5-ketone
06/09/2010CN101723955A Method for preparing olanzapine
06/09/2010CN101723954A Technique for preparing olanzapine
06/08/2010US7732608 Clopidogrel p-toluenesulfonate (or Clopidogrel tosylate), Clopidogrel benzenesulfonate (or Clopidogrel besylate) and Clopidogrel methanesulfonate (or Clopidogrel mesylate); antianginal agent, antiplatelet agent; decreases morbid events in people with established atherosclerotic disease
06/08/2010US7732604 Triazolopyrazine derivatives
06/08/2010US7732603 Organic compounds as agents for the treatment of aldosterone mediated conditions
06/08/2010US7732507 Spirotetrathiocarbamates and spirooxothiocarbamates
06/08/2010US7732454 Inhibitors of Bruton's tyrosine kinase
06/03/2010WO2010061398A1 Process for preparing dorzolamide hydrochloride and its intermediate
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 214